English
Home > Products > CAS NO 191732-72-6

China CAS NO 191732-72-6 Factory

We depend on sturdy technical force and continually create sophisticated technologies to meet the demand of CAS NO 191732-72-6,191732-72-6,Lenalidomide API,Lenalidomide, Top quality, timely company and Aggressive cost, all win us a superior fame in xxx field despite the international intense competition.
CAS NO 191732-72-6, To achieve reciprocal advantages, our company is widely boosting our tactics of globalization in terms of communication with overseas customers, fast delivery, the best quality and long-term cooperation. Our company upholds the spirit of "innovation, harmony, team work and sharing, trails, pragmatic progress". Give us a chance and we'll prove our capability. With your kind help, we believe that we can create a bright future with you together.

Related Products

Hot Products

  • Methotrexate disodium salt

    Methotrexate disodium salt

    Product Name:Methotrexate disodium salt
    Molecular Formula:C20H23N8NaO5
    Molecular Weight:478.44
    CAS Registry Number;7413-34-5
  • Dasiglucagon

    Dasiglucagon

    Product Name:Dasiglucagon
    Molecular Formula:C152H222N38O50
    Molecular Weight;3381.66
    CAS Registry Number;1544300-84-6
  • 2,4-Difluorobenzaldehyde

    2,4-Difluorobenzaldehyde

    Product Name:2,4-Difluorobenzaldehyde
    Molecular Formula:C7H4F2O
    Molecular Weight:142.1
    CAS Registry Number:1550-35-2
  • 4-Oxo-9,10-dihydro-4H-benzo(4,5)-cyclohepta-(1,2b)thiophene

    4-Oxo-9,10-dihydro-4H-benzo(4,5)-cyclohepta-(1,2b)thiophene

    Product Name:4-Oxo-9,10-dihydro-4H-benzo(4,5)-cyclohepta-(1,2b)thiophene
    Molecular Formula:C13H10OS
    Molecular Weight:214.28
    CAS Registry Number:1622-55-5
  • Ruthenium(III) chloride hydrate(1:x)

    Ruthenium(III) chloride hydrate(1:x)

    Product Name:Ruthenium(III) chloride hydrate(1:x)
    Molecular Formula:Cl3H2ORu
    Molecular Weight:225.44
    CAS Registry Number:14898-67-0
  • 4-(2-Bromoacetyl)benzonitrile

    4-(2-Bromoacetyl)benzonitrile

    Product Name:4-(2-Bromoacetyl)benzonitrile
    Molecular Formula:C9H6BrNO
    Molecular Weight:224.05
    CAS Registry Number:20099-89-2
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept